Primjeri korištenja Was evaluated na Engleski i njihovi prijevodi na Hrvatskom
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The efficacy of Xiapex was evaluated in two randomized, double-blind,
Virologic response rate was evaluated in both treatment arms
The efficacy and safety of empagliflozin as monotherapy was evaluated in a double-blind, placebo-
The pharmacokinetics of eculizumab was evaluated in Study M07-005 including 7 PNH paediatric patients aged from 11 to less than 18 years.
at 15 to 18 months of age was evaluated in 44 very preterm,
In the second evaluation, the BCOP test method was evaluated for its usefulness to identify chemicals(substances
The safety of HyQvia was evaluated in 4 clinical studies(160602,
without metformin and/or a sulphonylurea was evaluated in a double-blind, placebo-controlled trial of 78 weeks duration.
In two long-term studies, the efficacy of epoetin theta was evaluated in 124 haemodialysis patients
In the first evaluation, the BCOP test method was evaluated for its usefulness to identify chemicals(substances
The safety and immunogenicity of Nimenrix was evaluated when sequentially administered
Each dose level of mirabegron and moxifloxacin was evaluated in separate treatment arms each including placebo-control parallel cross-over design.
The absorption of brimonidine from Mirvaso was evaluated in a clinical study in 24 adult subjects with facial erythema of rosacea.
The safety of Strimvelis was evaluated in 18 subjects, with a median duration of follow-up of 7 years.
when handicraft and housekeeping of the future wife was evaluated.
The efficacy of pramipexole(0.0625-0.5 mg/day) with paediatric patients aged 6-17 years with Tourette Disorder was evaluated in a 6-week, double-blind, randomised, placebo-controlled flexible dose study.
The pharmacokinetics of 150 mg pregabalin given every 12 hours(300 mg daily dose) was evaluated in 10 lactating women who were at least 12 weeks postpartum.
The use of ribavirin in combination treatment with interferon alfa-2b was evaluated in a number of clinical trials.
The effect of dulaglutide on blood pressure as assessed by Ambulatory Blood Pressure Monitoring was evaluated in a study of 755 patients with type 2 diabetes.
The pharmacokinetics of aliskiren was evaluated in rats aged from 8 to 28 days after intravenous administration of aliskiren 3 mg/kg.